AG013736
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AG013736, covering 2012-03-26 to 2012-03-26. Get the full timeline:
Most recent: Clinical Trial Update: First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors [Phase 1]